Perioperative  ||| S:0 E:14 ||| JJ
central  ||| S:14 E:22 ||| JJ
nervous  ||| S:22 E:30 ||| JJ
system  ||| S:30 E:37 ||| NN
injury  ||| S:37 E:44 ||| NN
in  ||| S:44 E:47 ||| IN
neonates  ||| S:47 E:56 ||| FW
Anaesthetic-induced  ||| S:56 E:76 ||| FW
developmental  ||| S:76 E:90 ||| FW
neurotoxicity  ||| S:90 E:104 ||| FW
( ||| S:104 E:105 ||| -LRB-
AIDN ||| S:105 E:109 ||| NNP
)  ||| S:109 E:111 ||| -RRB-
has  ||| S:111 E:115 ||| VBZ
been  ||| S:115 E:120 ||| VBN
clearly  ||| S:120 E:128 ||| RB
established  ||| S:128 E:140 ||| VBN
in  ||| S:140 E:143 ||| IN
laboratory  ||| S:143 E:154 ||| NN
animal  ||| S:154 E:161 ||| NN
models ||| S:161 E:167 ||| NNS
.  ||| S:167 E:169 ||| .
The  ||| S:169 E:173 ||| DT
possibility  ||| S:173 E:185 ||| NN
of  ||| S:185 E:188 ||| IN
neurotoxicity  ||| S:188 E:202 ||| NN
during  ||| S:202 E:209 ||| IN
uneventful  ||| S:209 E:220 ||| JJ
anaesthetic  ||| S:220 E:232 ||| JJ
procedures  ||| S:232 E:243 ||| NNS
in  ||| S:243 E:246 ||| IN
human  ||| S:246 E:252 ||| JJ
neonates  ||| S:252 E:261 ||| NN
or  ||| S:261 E:264 ||| CC
infants  ||| S:264 E:272 ||| NN
has  ||| S:272 E:276 ||| VBZ
led  ||| S:276 E:280 ||| VBN
to  ||| S:280 E:283 ||| TO
serious  ||| S:283 E:291 ||| JJ
questions  ||| S:291 E:301 ||| NNS
about  ||| S:301 E:307 ||| IN
the  ||| S:307 E:311 ||| DT
safety  ||| S:311 E:318 ||| NN
of  ||| S:318 E:321 ||| IN
paediatric  ||| S:321 E:332 ||| JJ
anaesthesia ||| S:332 E:343 ||| NN
.  ||| S:343 E:345 ||| .
However ||| S:345 E:352 ||| RB
,  ||| S:352 E:354 ||| ,
the  ||| S:354 E:358 ||| DT
applicability  ||| S:358 E:372 ||| NN
of  ||| S:372 E:375 ||| IN
animal  ||| S:375 E:382 ||| JJ
data  ||| S:382 E:387 ||| NNS
to  ||| S:387 E:390 ||| TO
clinical  ||| S:390 E:399 ||| JJ
anaesthesia  ||| S:399 E:411 ||| JJ
practice  ||| S:411 E:420 ||| NN
remains  ||| S:420 E:428 ||| VBZ
uncertain ||| S:428 E:437 ||| JJ
.  ||| S:437 E:439 ||| .
The  ||| S:439 E:443 ||| DT
spectre  ||| S:443 E:451 ||| NN
of  ||| S:451 E:454 ||| IN
cerebral  ||| S:454 E:463 ||| JJ
injury  ||| S:463 E:470 ||| NN
due  ||| S:470 E:474 ||| JJ
to  ||| S:474 E:477 ||| TO
cerebral  ||| S:477 E:486 ||| VB
hypoperfusion ||| S:486 E:499 ||| NNS
,  ||| S:499 E:501 ||| ,
metabolic  ||| S:501 E:511 ||| JJ
derangements ||| S:511 E:523 ||| NN
,  ||| S:523 E:525 ||| ,
coexisting  ||| S:525 E:536 ||| JJ
disease ||| S:536 E:543 ||| NN
,  ||| S:543 E:545 ||| ,
and  ||| S:545 E:549 ||| CC
surgery  ||| S:549 E:557 ||| NN
itself  ||| S:557 E:564 ||| PRP
further  ||| S:564 E:572 ||| RB
muddles  ||| S:572 E:580 ||| VB
the  ||| S:580 E:584 ||| DT
picture ||| S:584 E:591 ||| NN
.  ||| S:591 E:593 ||| .
Given  ||| S:593 E:599 ||| VBN
the  ||| S:599 E:603 ||| DT
potential  ||| S:603 E:613 ||| JJ
magnitude  ||| S:613 E:623 ||| NN
of  ||| S:623 E:626 ||| IN
the  ||| S:626 E:630 ||| DT
public  ||| S:630 E:637 ||| JJ
health  ||| S:637 E:644 ||| NN
importance  ||| S:644 E:655 ||| NN
of  ||| S:655 E:658 ||| IN
this  ||| S:658 E:663 ||| DT
issue ||| S:663 E:668 ||| NN
,  ||| S:668 E:670 ||| ,
the  ||| S:670 E:674 ||| DT
clinician  ||| S:674 E:684 ||| NN
should  ||| S:684 E:691 ||| MD
be  ||| S:691 E:694 ||| VB
cognisant  ||| S:694 E:704 ||| VBN
of  ||| S:704 E:707 ||| IN
the  ||| S:707 E:711 ||| DT
literature  ||| S:711 E:722 ||| NN
and  ||| S:722 E:726 ||| CC
ongoing  ||| S:726 E:734 ||| JJ
investigations  ||| S:734 E:749 ||| NNS
on  ||| S:749 E:752 ||| IN
AIDN ||| S:752 E:756 ||| NNP
,  ||| S:756 E:758 ||| ,
and  ||| S:758 E:762 ||| CC
raise  ||| S:762 E:768 ||| VB
awareness  ||| S:768 E:778 ||| NN
of  ||| S:778 E:781 ||| IN
the  ||| S:781 E:785 ||| DT
risks  ||| S:785 E:791 ||| NNS
of  ||| S:791 E:794 ||| IN
both  ||| S:794 E:799 ||| DT
surgery  ||| S:799 E:807 ||| NN
and  ||| S:807 E:811 ||| CC
anaesthesia ||| S:811 E:822 ||| NN
.  ||| S:822 E:824 ||| .
